
Bharat Parenterals Ltd. (BPLPHARMA): Bharat Parenterals Share Price near 52-week high as stock trades at Rs 1,625
Updated: 25 Sept 2026 • 9:52 am
Posted by:

Bharat Parenterals Share Price is trading at Rs 1,625, up 2.90% today, close to its 52-week high with market capitalisation at Rs 1,059.26 crore.
Bharat Parenterals Share Price is in focus today after the stock traded at Rs 1,625, up Rs 45.75 from the previous close, and stayed close to its 52-week high. The move leaves the company with a market capitalisation of Rs 1,059.26 crore, which places Bharat Parenterals Share Price firmly on the radar of readers tracking Bharat Parenterals Share Price Today and Bharat Parenterals Stock News. The latest Univest figures confirm the price event, but they do not establish a company-specific catalyst. For investors following Bharat Parenterals Share Price Live, the key question is how this price level compares with the company’s valuation, earnings trend and sector backdrop.
Bharat Parenterals Share Price Today: Price Action Analysis
As of 25 September 2026 at 9:48 AM IST, Bharat Parenterals Share Price was trading between Rs 1,590.05 and Rs 1,630 during the day, starting at Rs 1,600. The stock’s latest move keeps Bharat Parenterals Share Price in the near-peak zone for the year, making it relevant for Bharat Parenterals News Today, Bharat Parenterals Share Price Update and Bharat Parenterals Share News searches. Univest continues to track the move as a stock-market event rather than a commentary on motive, and the data points to a price that remains near its yearly high while the broader financial context still needs to be read carefully.
| Metric | Value |
|---|---|
| Current Price | Rs 1,625 |
| Previous Close | Rs 1,579.25 |
| Today's Move | +Rs 45.75 (+2.9%) |
| Open | Rs 1,600 |
| High | Rs 1,630 |
| Low | Rs 1,590.05 |
| Market Capitalisation | Rs 1,059.26 crore |
Bharat Parenterals Ltd. (BPLPHARMA) traded at Rs 1,625 versus the previous close of Rs 1,579.25, a rise of 2.9%. The stock opened at Rs 1,600, reached a high of Rs 1,630 and touched a low of Rs 1,590.05.
Bharat Parenterals Share Price Today shows a clear upward move from the previous close of Rs 1,579.25 to Rs 1,625, a gain of Rs 45.75 or 2.90%. The stock opened at Rs 1,600, moved between Rs 1,590.05 and Rs 1,630, and is trading just Rs 5 below its 52-week high. Bharat Parenterals Share Price therefore sits very close to its one-year high and remains a key name in Bharat Parenterals Stock News and Bharat Parenterals Share Price Update coverage.
That narrow gap between the latest traded level and the yearly high is the main factual feature of the session. Bharat Parenterals Share Price Today reflects a market that is keeping the stock near the upper end of its range, but the data only confirms the price event. It does not identify a company-specific trigger, and it does not justify any unsupported explanation for why Bharat Parenterals Share Price is moving. For readers watching Bharat Parenterals NSE and Bharat Parenterals BSE, the most important fact remains the proximity to the 52-week high and the stock’s day range.
Bharat Parenterals Ltd. (BPLPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,059.26 crore |
| P/E Ratio | 38.67x |
| P/B Ratio | 3.42x |
| ROE | -8.36% |
| ROCE | -1.82% |
| EPS | Rs -22.35 |
| Book Value Per Share | Rs 462.38 |
| Dividend Yield | 0.06% |
Bharat Parenterals Ltd. (BPLPHARMA) fundamental metrics show P/E 38.67x, P/B 3.42x, ROE -8.36%, ROCE -1.82%. These figures provide context only and are not a buy or sell signal.
Bharat Parenterals Ltd. has a market capitalisation of Rs 1059.26 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 38.67x, P/B at 3.42x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -8.36% and ROCE of -1.82%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -22.35, book value per share of Rs 462.38, dividend yield of 0.06%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.18x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 38.67x |
| Benchmark Median P/E | 28.18x |
| Benchmark Average P/E | 42.32x |
| Benchmark P/E Range | 0x to 757.76x |
| Company P/B Ratio | 3.42x |
| Benchmark Median P/B | 2.91x |
| Company ROE | -8.36% |
| Benchmark Median ROE | 11.74% |
| Company ROCE | -1.82% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 1,059.26 crore |
| Benchmark Median Market Cap | Rs 793.62 crore |
Bharat Parenterals Ltd. (BPLPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Bharat Parenterals Ltd. (BPLPHARMA) has a P/E ratio of 38.67x, which is above the benchmark median of 28.18x, a difference of +37.22%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Bharat Parenterals Ltd. (BPLPHARMA) has a ROE of -8.36%, which is below the benchmark median of 11.74%, a difference of -171.21%. Bharat Parenterals Ltd. (BPLPHARMA) has a ROCE of -1.82%, which is below the benchmark median of 13.63%, a difference of -113.35%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sudarshan Pharma Industries Ltd. | SUDARSHAN | 1,017.37 | 38.67 | 2.96 | 13.33 | 14.42 |
| Themis Medicare Ltd. | THEMISMED | 1,123.62 | 27.28 | 2.81 | 7.65 | 10.37 |
| Bajaj Healthcare Ltd. | BAJAJHCARE | 1,179.46 | 51.22 | 2.16 | 4.35 | 7.04 |
| Shree Ganesh Remedies Ltd. | SGRL | 943.05 | 56.52 | 5.32 | 11.53 | 14.63 |
| Sigachi Industries Ltd. | SIGACHI | 1,197.17 | 45.76 | 2.19 | -14.75 | -10.72 |
Bharat Parenterals Ltd. (BPLPHARMA) has a P/E ratio of 38.67x compared with the displayed peer median of 45.76x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -8.36% compares with a peer median of 7.65% across the companies shown in the table. ROCE stood at -1.82% versus the displayed peer median of 10.37%, providing a capital-efficiency comparison. Bharat Parenterals Ltd. (BPLPHARMA) has a market capitalisation of Rs 1,059.26 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Bharat Parenterals
- Bharat Parenterals Share Price is trading at Rs 1,625, close to its 52-week high.
- Bharat Parenterals Share Price Today is higher by Rs 45.75, or 2.90%, versus the previous close.
- The company’s market capitalisation stands at Rs 1,059.26 crore.
- Bharat Parenterals Fundamental Analysis shows P/E of 38.67 and P/B of 3.42.
- ROE is -8.36%, ROCE is -1.82% and EPS is -22.35, which keeps Bharat Parenterals Stock News relevant for value comparison.
About Bharat Parenterals
Bharat Parenterals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is listed on NSE and BSE under the symbol BPLPHARMA. Bharat Parenterals Share Price is therefore tracked not only as a daily market quote but also as a company-specific event within the wider pharmaceutical universe. For readers scanning Bharat Parenterals Company News, the most useful context is the combination of sector classification, valuation metrics and recent financial figures that define Bharat Parenterals Stock Performance today.
Univest tracks Bharat Parenterals Share Price, Bharat Parenterals Share Price Today and Bharat Parenterals Share News so readers can follow the latest quote, the 52-week high context, market cap, valuation measures and company financials in one place. Bharat Parenterals Share Price analysis on Univest also helps users compare the stock with peers, sector benchmarks and the broader Indian stock market without relying on headlines alone.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Bharat Parenterals Share Price in focus today?
Ans. Bharat Parenterals Share Price is in focus because it traded at Rs 1,625, just below its 52-week high. The move also lifted the stock 2.90% from the previous close.
What is Bharat Parenterals Share Price today?
Ans. Bharat Parenterals Share Price today is Rs 1,625. It moved up Rs 45.75 from the previous close of Rs 1,579.25 and stayed close to the year’s peak. The stock moved 2.9% so far today.
How far is Bharat Parenterals Share Price from its 52-week high?
Ans. Bharat Parenterals Share Price is Rs 5 below its 52-week high. That narrow gap is the main reason the stock is drawing attention in Bharat Parenterals Stock News.
What does Bharat Parenterals fundamental analysis show?
Ans. Bharat Parenterals Fundamental Analysis shows market capitalisation of Rs 1,059.26 crore, P/E of 38.67, P/B of 3.42, ROE of -8.36% and ROCE of -1.82%, which creates a mixed earnings picture.
What is Bharat Parenterals EPS and book value?
Ans. Bharat Parenterals EPS is -22.35 and book value per share is Rs 462.38. Those figures help explain the gap between Bharat Parenterals Share Price and the company’s current profitability profile.
How does Bharat Parenterals compare with sector benchmarks?
Ans. Bharat Parenterals Share Price implies a P/E above the industry median of 28.18 and below the industry average of 42.32. Its P/B of 3.42 is also above the median of 2.91.
What does Bharat Parenterals revenue trend show?
Ans. Bharat Parenterals revenue was Rs 1,159.99 crore in Jun 25, Rs 646.2 crore in Sep 25, Rs 651.88 crore in Dec 25, Rs 996.24 crore in Mar 26 and Rs 937.36 crore in Jun 26.
Should investors monitor Bharat Parenterals Share Price on Univest?
Ans. Yes, Bharat Parenterals Share Price can be monitored on Univest for live updates, 52-week levels, valuation ratios, company financials and peer comparison. That makes Bharat Parenterals Share Price Today easier to track in context.
Track Bharat Parenterals Share Price on Univest
Use Bharat Parenterals Ltd. (BPLPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Bharat Parenterals Share Price on Univest for live price updates, 52-week levels, company financials, market cap, valuation ratios and peer context. Univest also helps readers follow Bharat Parenterals Share Price Today alongside Bharat Parenterals Stock News and Bharat Parenterals Latest News in one view.
Recent Articles

Davangere Sugar Company Ltd. (DAVANGERE): Davangere Sugar Company Share Price rises 9.59% to Rs 2.40
25 September 2026

Quess Corp (QUESS) Share Price Falls 5.61% as Stock Slips to Rs 332.90
25 September 2026

Avadh Sugar & Energy Ltd. (AVADHSUGAR): Avadh Sugar & Energy Share Price rises 9.69% as stock gains today
25 September 2026

Sar Televenture (SARTELE-SM) Share Price falls 8.69% to Rs 89.85
25 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Davangere Sugar Company Ltd. (DAVANGERE): Davangere Sugar Company Share Price rises 9.59% to Rs 2.40
Quess Corp (QUESS) Share Price Falls 5.61% as Stock Slips to Rs 332.90
Avadh Sugar & Energy Ltd. (AVADHSUGAR): Avadh Sugar & Energy Share Price rises 9.69% as stock gains today
Sar Televenture (SARTELE-SM) Share Price falls 8.69% to Rs 89.85
Primo Chemicals Share Price rises 10.32% as Primo Chemicals Ltd. (PRIMO) gains today
Popular this week
Allied Blenders And Distillers Ltd. (ABDL) 52 Week High Streak: Second Straight Session Near Yearly Peak

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





